Cervical cancer is preventable and curable, as long as it is detected early and managed effectively. Yet it is the 4th most common form of cancer among women worldwide, with the disease claiming the lives of more than 300 000 women in 2018.
Few diseases reflect global inequities as much as cancer of the cervix. Nearly 90% of the deaths in 2018 occurred in low- and middle-income countries. This is where the burden of cervical cancer is greatest, because access to public health services is limited and screening and treatment for the disease have not been widely implemented.
An ambitious, concerted and inclusive strategy has been developed to guide the elimination of cervical cancer as a public health problem.
In May 2018, the WHO Director-General announced a global call for action to eliminate cervical cancer, underscoring renewed political will to make elimination a reality and calling for all stakeholders to unite behind this common goal.
In August 2020 the World Health Assembly adopted the Global Strategy for cervical cancer elimination.
Now is the time to act to eliminate cervical cancer as a public health problem.
To eliminate cervical cancer, all countries must reach and maintain an incidence rate of below 4 per 100 000 women. Achieving that goal rests on three key pillars and their corresponding targets:
Each country should meet the 90–70–90 targets by 2030 to get on the path to eliminate cervical cancer within the next century.
The knowledge repository is a user-friendly portal providing “one-stop" access to resources and tools that offer support for cervical cancer elimination.
The Western Pacific Region accounts for one-fourth of the global cervical cancer burden, and approximately 90% of that burden is in lower-middle-income...
Self-care interventions are evidence-based, quality drugs, devices, diagnostics and/or digital products which can be provided fully or partially outside...
Realization of Sexual and reproductive health and rights (SRHR) requires provision of comprehensive, people-centred services, that address the different...
This policy brief focuses on the use of and the differences between HPV DNA-based and HPV mRNA-based molecular nucleic acid amplification tests...
WHO cervical cancer prevention and control costing tool
* This resource lists technologies as of 2019 for screening, triage and treatment of cervical cancer
Women and girls
Community groups
Health care professionals
Governments and policy-makers
Partner story